Diagnostic markers reflecting dysregulation of the host response in the transition to tuberculosis disease

Abstract

Sustained control of Mycobacterium tuberculosis infection without evidence of disease is based on a finely tuned balance between pro- and anti-inflammatory responses. Loss of this balance leads to tuberculosis (TB) disease, in which exacerbated myeloid and neutrophil activation is common. Proteomic and transcriptomic assessment of the host response can detect increasing immune activation associated with TB disease progression several months before clinical disease. Future diagnostic methods based on measuring host response biomarkers that are able to detect this dysregulation could therefore be valuable in the early detection of TB disease progression.

Keywords

• Tuberculosis
• Biomarkers
• Diagnostics
• Proteomics
• Transcriptomics
• Immune response